Pitcairn’s Dentsply Sirona XRAY Stock Holding History

Pitcairn’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,082	Closed	-$160K	–	723
2025 Q2	$160K	Buy	+10,082	New	+$151K	0.01%	677

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pitcairn's XRAY Position: Q3 2025 in Review

Pitcairn sold out of Dentsply Sirona (XRAY) in Q3 2025, closing a stake of 10,082 shares — an estimated $160K sold.

Pitcairn first reported a position in XRAY in Q2 2025 and held it in 1 quarter. The position peaked at $160K in Q2 2025. 411 funds tracked by Wall St. Rank hold XRAY as of Q3 2025.

Pitcairn reported no remaining Dentsply Sirona position as of Q3 2025 after selling out during the quarter.
Pitcairn sold 10,082 Dentsply Sirona shares in Q3 2025, an estimated $160K.
Pitcairn first reported a position in Dentsply Sirona in Q2 2025 and held it in 1 quarter.
Pitcairn's Dentsply Sirona position peaked at $160K in Q2 2025.
411 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2025.

Based on Pitcairn's 13F filing for Q3 2025, filed 12 Nov 2025.